U.S. Intravenous Solutions Market Size, Share & Trends Analysis Report By Type (TPN, PPN), By Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. Intravenous Solutions Market Growth & Trends
The U.S. intravenous solutions market size is anticipated to reach USD 7.90 billion by 2030 and is projected to grow at a CAGR of 7.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is observed due to the rising prevalence of diseases, and the increasing number of surgeries. In addition, the rising number of geriatric population susceptible to non-communicable diseases such as cancer, neurological disorders, cardiovascular disorders, and spinal injuries is likely to impact market growth.
The increasing number of hospitals, ambulatory surgical centers, intravenous (IV) solutions infusion centers, and med spas contribute to the market growth. According to the data published by the Ambulatory Surgery Center Association, the number of ambulatory surgery centers in the U.S. in 2022 was 6087, out of which California state had the highest number (848), followed by Florida state (468).
IV hydration therapy is a highly effective treatment for severe dehydration. Individuals with certain chronic illnesses, such as diabetes or certain kidney conditions, may be at a greater risk of dehydration. Rehydration therapy helps to restore the proper electrolyte balance in the body. The most commonly used IV treatment is a simple saline solution that contains water and sodium chloride. However, solutions containing sugar, such as glucose, dextrose, or levulose, are also frequently used. For instance, in December 2023, Baxter, a prominent figure in infusion therapies and technologies, completed the initial phase of its pilot program for IV bag recycling with Northwestern Medicine. This effort has diverted over six tons of PVC IV bag waste from landfills. This amount could stretch across Chicago if laid end-to-end, promoting environmentally sustainable reuse.
U.S. Intravenous Solutions Market Report Highlights
U.S. Intravenous Solutions Market Growth & Trends
The U.S. intravenous solutions market size is anticipated to reach USD 7.90 billion by 2030 and is projected to grow at a CAGR of 7.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is observed due to the rising prevalence of diseases, and the increasing number of surgeries. In addition, the rising number of geriatric population susceptible to non-communicable diseases such as cancer, neurological disorders, cardiovascular disorders, and spinal injuries is likely to impact market growth.
The increasing number of hospitals, ambulatory surgical centers, intravenous (IV) solutions infusion centers, and med spas contribute to the market growth. According to the data published by the Ambulatory Surgery Center Association, the number of ambulatory surgery centers in the U.S. in 2022 was 6087, out of which California state had the highest number (848), followed by Florida state (468).
IV hydration therapy is a highly effective treatment for severe dehydration. Individuals with certain chronic illnesses, such as diabetes or certain kidney conditions, may be at a greater risk of dehydration. Rehydration therapy helps to restore the proper electrolyte balance in the body. The most commonly used IV treatment is a simple saline solution that contains water and sodium chloride. However, solutions containing sugar, such as glucose, dextrose, or levulose, are also frequently used. For instance, in December 2023, Baxter, a prominent figure in infusion therapies and technologies, completed the initial phase of its pilot program for IV bag recycling with Northwestern Medicine. This effort has diverted over six tons of PVC IV bag waste from landfills. This amount could stretch across Chicago if laid end-to-end, promoting environmentally sustainable reuse.
U.S. Intravenous Solutions Market Report Highlights
- Based on type, the total parenteral nutrition segment led the market with the largest revenue share of 67.02% in 2023, owing to the increased number of chronic disorders and the surgeries need to treat them
- Based on nutrients, the vitamins and minerals (salt and electrolyte) segment is expected to grow at the fastest CAGR of 10.0% over the forecast period
- Based on nutrients, The single dose amino acids segment led the market with the largest revenue share 31.27% in 2023
- In September 2020, Baxter got the U.S. FDA approval to develop new formulations of its product Clinimix to provide more protein while delivering less dextrose
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Nutrients
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Nutrients outlook
2.3. Competitive Insights
CHAPTER 3. U.S. INTRAVENOUS SOLUTIONS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Intravenous Solutions Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. INTRAVENOUS SOLUTIONS MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Intravenous Solutions Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Total Parenteral Nutrition (TPN)
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.2. Peripheral Parenteral Nutrition (PPN)
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
CHAPTER 5. U.S. INTRAVENOUS SOLUTIONS MARKET: NUTRIENTS ESTIMATES & TREND ANALYSIS
5.1. Nutrients Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Intravenous Solutions Market by Nutrients Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Carbohydrates
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.2. Single dose amino acids
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.3. Vitamins and minerals
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.4. Parenteral lipid emulsion
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.5. Others
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company heat map analysis, 2023
6.4. Company Profiles
6.4.1. Fresenius Kabi AG
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. Pfizer Inc.
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Baxter
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. ICU Medical
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Option Care Health Inc.
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. B. Braun Medical Inc
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Nutrients
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Nutrients outlook
2.3. Competitive Insights
CHAPTER 3. U.S. INTRAVENOUS SOLUTIONS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Intravenous Solutions Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. INTRAVENOUS SOLUTIONS MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Intravenous Solutions Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Total Parenteral Nutrition (TPN)
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.2. Peripheral Parenteral Nutrition (PPN)
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
CHAPTER 5. U.S. INTRAVENOUS SOLUTIONS MARKET: NUTRIENTS ESTIMATES & TREND ANALYSIS
5.1. Nutrients Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Intravenous Solutions Market by Nutrients Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Carbohydrates
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.2. Single dose amino acids
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.3. Vitamins and minerals
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.4. Parenteral lipid emulsion
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
5.4.5. Others
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company heat map analysis, 2023
6.4. Company Profiles
6.4.1. Fresenius Kabi AG
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. Pfizer Inc.
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Baxter
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. ICU Medical
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Option Care Health Inc.
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. B. Braun Medical Inc
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
LIST OF TABLES
Table 1. List of abbreviations
Table 2. U.S. Intravenous solutions market, by type, 2018 - 2030 (USD Billion)
Table 3. U.S. Intravenous solutions market, by type, 2018 - 2030 (Thousand Units)
Table 4. U.S. Intravenous solutions market, by nutrients, 2018 - 2030 (USD Billion)
Table 1. List of abbreviations
Table 2. U.S. Intravenous solutions market, by type, 2018 - 2030 (USD Billion)
Table 3. U.S. Intravenous solutions market, by type, 2018 - 2030 (Thousand Units)
Table 4. U.S. Intravenous solutions market, by nutrients, 2018 - 2030 (USD Billion)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. intravenous solutions market: market outlook
Fig. 9 U.S. intravenous solutions competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. intravenous solutions market driver impact
Fig. 14 U.S. intravenous solutions market restraint impact
Fig. 15 U.S. intravenous solutions: Type movement analysis
Fig. 16 U.S. intravenous solutions: Type outlook and key takeaways
Fig. 17 Total parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 18 Peripheral parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 19 U.S. intravenous solutions: Nutrients movement analysis
Fig. 20 U.S. intravenous solutions: Nutrients outlook and key takeaways
Fig. 21 Carbohydrates market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Single dose amino acids market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 23 Vitamins and minerals market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 24 Parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. intravenous solutions market: market outlook
Fig. 9 U.S. intravenous solutions competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. intravenous solutions market driver impact
Fig. 14 U.S. intravenous solutions market restraint impact
Fig. 15 U.S. intravenous solutions: Type movement analysis
Fig. 16 U.S. intravenous solutions: Type outlook and key takeaways
Fig. 17 Total parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 18 Peripheral parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 19 U.S. intravenous solutions: Nutrients movement analysis
Fig. 20 U.S. intravenous solutions: Nutrients outlook and key takeaways
Fig. 21 Carbohydrates market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Single dose amino acids market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 23 Vitamins and minerals market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 24 Parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
